The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. For the above reasons, Medindia cannot be held ...

Glenmark Pharmaceuticals today said it has received three observations from the US health regulator for its Pithampur, Indore plant. (Source: website) Glenmark Pharmaceuticals has entered into an ...

Basel, April 30, 2014 - Novartis today announced positive first results from the Phase III head-to-head LANTERN study, which showed the superiority of once-daily ...

Glenmark Pharmaceuticals Europe Ltd has entered into a strategic development and licensing agreement with Celon Pharma SA to develop and market a generic version of GSK's Seretide Accuhaler product - ...

Regulatory approval for the generic version of GlaxoSmithKline's Seretide Accuhaler in the Nordic region is Glenmark's first inhaled respiratory product approval in Europe ...

"Glenmark Pharmaceuticals Europe today has entered into a strategic development & licensing agreement with Celon Pharma SA to develop and market a generic version of GlaxoSmithKline's Seretide ...

(Alliance News) - Vectura Group PLC on Friday said the English High Court dismissed a case against Sandoz Ltd's generic version of GlaxsmithKline PLC's Seretide Accuhaler. The case was bought against ...

(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

LONDON & BRISBANE, Calif.--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has approved a label update for the use of ...